3.52
+0.07(+2.03%)
Currency In USD
| Previous Close | 3.45 |
| Open | 3.45 |
| Day High | 3.56 |
| Day Low | 3.4 |
| 52-Week High | 82.8 |
| 52-Week Low | 2.36 |
| Volume | 39,683 |
| Average Volume | 2.12M |
| Market Cap | 2.51M |
| PE | 0.08 |
| EPS | 41.76 |
| Moving Average 50 Days | 3.41 |
| Moving Average 200 Days | 6.16 |
| Change | 0.07 |
If you invested $1000 in Psyence Biomedical Ltd. Common Shares (PBM) since IPO date, it would be worth $0.94 as of October 18, 2025 at a share price of $3.52. Whereas If you bought $1000 worth of Psyence Biomedical Ltd. Common Shares (PBM) shares 1 year ago, it would be worth $0.94 as of October 18, 2025 at a share price of $3.52.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacific Bay Announces Non-Brokered Financing
Newsfile
Sep 25, 2025 8:33 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - David H. Brett, Chairman of Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") reports that the Company is pleased to announce a non-brokered private placement o
Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025
Newsfile
Jun 18, 2025 12:30 PM GMT
Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS)Denver, Colorado--(Newsfile Corp. - June 18, 2025) - Psyence Biomedical
Psyence Biomed Regains Full Compliance with NASDAQ Continued Listing Requirements
Newsfile
Jun 17, 2025 12:00 PM GMT
New York, New York--(Newsfile Corp. - June 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasdaq Hearings Panel confirming that the Company has r